Inovio Pharmaceuticals In... (INO)
NASDAQ: INO
· Real-Time Price · USD
2.21
0.09 (4.25%)
At close: Jun 06, 2025, 10:16 AM
4.25% (1D)
Bid | 2.2 |
Market Cap | 81.05M |
Revenue (ttm) | 217.76K |
Net Income (ttm) | -44.91B |
EPS (ttm) | -3.08 |
PE Ratio (ttm) | -0.72 |
Forward PE | -1.22 |
Analyst | Hold |
Ask | 2.21 |
Volume | 139,092 |
Avg. Volume (20D) | 639,623 |
Open | 2.15 |
Previous Close | 2.12 |
Day's Range | 2.14 - 2.23 |
52-Week Range | 1.42 - 12.33 |
Beta | 1.31 |
Analyst Forecast
According to 0 analyst ratings, the average rating for INO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-1.7%
Shares of industrial stocks are trading lower foll...
Unlock content with
Pro Subscription
4 months ago
+18.13%
Shares of vaccine makers are trading higher after the first bird flu death was reporting in the US. Additionally, a recent CDC report noted an increase in acute respiratory illness activity.

3 weeks ago · seekingalpha.com
Inovio Pharmaceuticals, Inc. (INO) Q1 2025 Earnings Call TranscriptInovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Jennie Willson - IR Jacqui Shea - President & CEO Mike Sumner - Chief Medical O...

2 months ago · seekingalpha.com
Inovio Pharmaceuticals, Inc. (INO) Q4 2024 Earnings Call TranscriptInovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q4 2024 Earnings Conference Call March 18, 2025 4:30 PM ET Company Participants Jennie Willson - IR Jacqui Shea - President & CEO Mike Sumner - Chief Medical...